Poly Medicure Stock Price Analysis and Quick Research Report. Is Poly Medicure an attractive stock to invest in?
Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.
Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements.
Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Poly Medicure.
-
PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Poly Medicure has a PE ratio of 58.2823967127992 which is high and comparatively overvalued.
-
Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Poly Medicure has ROA of 12.9373% which is a bad sign for future performance. (Higher values are always desirable.)
-
Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Poly Medicure has a Current ratio of 4.5361.
-
Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Poly Medicure has a ROE of 15.7899%. (Higher is better)
-
Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Poly Medicure has a Debt to Equity ratio of 0.0619 which means that the company has low proportion of debt in its capital.
-
Sales growth: Poly Medicure has reported revenue growth of 22.5321% which is fair in relation to its growth and performance.
-
Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Poly Medicure for the current financial year is 27.934939185284%.
-
Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Poly Medicure is Rs 3.5 and the yield is 0.175%.
-
Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Poly Medicure is Rs 34.2419. The higher the EPS, the better it is for investors.
One can find all the Financial Ratios of Poly Medicure in Ticker for free. Also, one can get the intrinsic value of Poly Medicure by using Valuation Calculators, which are available with a Finology ONE subscription.
Poly Medicure FAQs
Q1. What is Poly Medicure share price today?
Ans: The current share price of Poly Medicure is Rs 1995.7.
Q2. What is the market capitalisation of Poly Medicure?
Ans: Poly Medicure has a market capitalisation of Rs 20221.57294255 Cr., calculated based on its latest share price.
Q3. What are the P/E and P/B ratios of Poly Medicure?
Ans: The PE ratio of Poly Medicure is 58.2823967127992 and the P/B ratio of Poly Medicure is 7.14577276177654, showing how the stock is valued against its earnings and book value.
Q4. What is the 52-week high and low of Poly Medicure share?
Ans: The 52-week high share price of Poly Medicure is Rs 3357.8, and the 52-week low share price of Poly Medicure is Rs 1821.2.
Q5. Does Poly Medicure pay dividends?
Ans: Currently, Poly Medicure pays dividends. Dividend yield of Poly Medicure is around 0.175%.
Q6. What are the face value and book value of Poly Medicure shares?
Ans: The face value of Poly Medicure shares is Rs 5, while the book value per share of Poly Medicure is around Rs 279.284. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.
Q7. What is the debt of Poly Medicure?
Ans: Poly Medicure has a total debt of Rs 169.8593 Cr., which affects investor sentiment and financial stability.
Q8. What are the ROE and ROCE of Poly Medicure?
Ans: The ROE of Poly Medicure is 15.7899% and ROCE of Poly Medicure is 20.1381%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.
Q9. Is Poly Medicure a good buy for the long term?
Ans: The Poly Medicure long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.
Q10. Is Poly Medicure undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Poly Medicure appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.
Q11. How to check Poly Medicure’s financials?
Ans: You can review Poly Medicure’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.